
According to a report by China News Network on January 3, the Guangzhou railway police recently successfully apprehended a man who was using an e-cigarette containing ethyl methylphenidate in the train restroom. The individual has been subjected to administrative penalties as per the law.
According to reports, this incident occurred on the Z111 train running between Ganzhou and Shaoguan East. A man was found lying in the restroom by the train police, using an e-cigarette alone. He appeared to be in a dazed state and showed no reaction to the sudden arrival of the police. After being woken up and questioned by the authorities, the man admitted to the fact that the e-cigarette contained the illegal substance ethyl methylamino cyclohexane. The train police then took the man to the police station at Guangzhou Station for further processing.
After undergoing urine drug testing, a man named Ma (pseudonym), 21 years old, unemployed, and holder of a standing ticket from Ganzhou to Shaoguan East, was confirmed to have tested positive for methamphetamine in his urine. Furthermore, he fully admitted to his illegal actions. According to Ma's recollection, he engaged in the use of an e-cigarette containing methamphetamine in the bathroom only after his phone became unusable. He also stated that he was well aware that methamphetamine had been officially classified as a narcotic and psychoactive drug, but still succumbed to impulsiveness and tried it a couple of times, ultimately being apprehended by the police. Currently, the Guangzhou Railway Police have lawfully punished Ma and confiscated his e-cigarette device and related items.
Since October 1, 2023, the use of methoxyflurane has officially been included in the list of anesthetic and psychotropic drugs. Any illegal activities such as use, smuggling, trafficking, transportation, or manufacturing involving methoxyflurane will be treated as a drug-related crime and prosecuted according to the law.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com